ARKADIOS WEALTH ADVISORS – CRISPR Therapeutics AG Transaction History
ARKADIOS WEALTH ADVISORS portfolio value:
$852,000
portfolio value
ARKADIOS WEALTH ADVISORS quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.63% | -216 shares | 47K | $65.35 | 13.03K |
| Q2 2022 | share | Increase | +0.20% | 26 shares | -25K | $60.77 | 13.25K |
| Q1 2022 | share | Increase | +3.15% | 404 shares | -141K | $62.77 | 13.22K |
| Q4 2021 | share | Increase | +7441.18% | 12.65K shares | 952K | $78.85 | 12.82K |
| Q3 2021 | share | 0.00% | 0 shares | -8K | $111.93 | 170 | |
| Q2 2021 | share | Increase | 0.00% | 170 shares | 27K | $161.89 | 170 |
| Q1 2021 | share | Decrease | -100.00% | -34 shares | -5K | $121.85 | 0 |
| Q4 2020 | share | Increase | +70.00% | 14 shares | 2.80K | $153.11 | 34 |
| Q3 2020 | share | 0.00% | 0 shares | 378 | $83.64 | 20 | |
| Q2 2020 | share | 0.00% | 0 shares | 970 | $73.49 | 20 | |
| Q1 2020 | share | Increase | 0.00% | 20 shares | 848 | $42.41 | 20 |